Passion IT Framework Moderna inks collaboration with ILCM to develop mRNA therapeutic for ultra-rare disease

Thursday, 09 Sep 2021 09:39 am

PassionIT News

Under this collaboration Moderna and ILCM will develop a new mRNA therapeutic (mRNA-3351) for Crigler-Najjar Syndrome Type 1 (CN-1), an ultra-rare disease. It is estimated that there are only approximately 70-100 known cases of CN-1 in the world.